pecfent
kyowa kirin holdings b.v. - fentanyl - pain; cancer - analgetika - pecfent er indiceret til behandling af gennembrudssmerter hos voksne, som allerede modtager vedligeholdelsesopioidbehandling til kronisk kræftsmerte. gennembrudssmerter er en forbigående forværring af smerte, der opstår på baggrund af ellers kontrolleret vedvarende smerte. patienter, der modtager vedligeholdelse opioidbehandling er dem, der tager mindst 60 mg oral morfin dagligt, mindst 25 mikrogram af transdermal fentanyl per time, mindst 30 mg oxycodon dagligt, mindst 8 mg oral hydromorphone dagligt eller en equi-smertestillende dosis af et andet opioid for en uge eller længere.
sublifen 100 mikrogram resoribletter, sublinguale
g.l. pharma gmbh - fentanyl - resoribletter, sublinguale - 100 mikrogram
wakix
bioprojet pharma - pitolisant - narkolepsi - andre narkotika stoffer - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
abstral 100 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 100 mikrogram
abstral 100 mikrogram resoribletter, sublinguale
orifarm a/s - fentanylcitrat - resoribletter, sublinguale - 100 mikrogram
abstral 100 mikrogram resoribletter, sublinguale
2care4 aps - fentanylcitrat - resoribletter, sublinguale - 100 mikrogram
abstral 200 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram
abstral 200 mikrogram resoribletter, sublinguale
orifarm a/s - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram
abstral 200 mikrogram resoribletter, sublinguale
2care4 aps - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram